Oncogenesis · 2014 · 41 citations · 30 references
MedicineCancer BiologyCell BiologyMolecular OncologySignal TransductionTumor ProgressionAngiogenesis In CancerCancer Cell SignalingMalignant NeoplasmsOncogenic Signaling PathwaysRas Family OncogenesSignal Transduction In CancerCell InvasionExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingProteolytic PathwaysRas SignalingRas Signaling PathwayRas-driven TumorigenesisVascular Endothelial Growth Factor
Filamins regulate cell locomotion and associate with diverse signaling molecules. We have recently found that targeting filamin A (FLNA) reduces RAS-induced lung adenocarcinomas. In this study, we explored the role of another major filamin isoform, filamin B (FLNB), in tumor development. In contrast to FLNA, we report that targeting FLNB enhances RAS-induced tumor growth and metastasis which is associated with higher matrix metallopeptidase-9 (MMP-9) and extracellular signal-regulated kinase (ERK) activity. Flnb deficiency in mouse embryonic fibroblasts results in increased proteolytic activity of MMP-9 and cell invasion mediated by the RAS/ERK pathway. Similarly, silencing FLNB in multiple human cancer cells increases the proteolytic activity of MMP-9 and tumor cell invasion. Furthermore, we observed that Flnb-deficient RAS-induced tumors display more capillary structures that is correlated with increased vascular endothelial growth factor-A (VEGF-A) secretion. Inhibition of ERK activation blocks phorbol myristate acetate-induced MMP-9 activity and VEGF-A secretion in vitro. In addition, silencing FLNB in human ovarian cancer cells increases secretion of VEGF-A that induces endothelial cells to form more vascular structures in vitro. We conclude that FLNB suppresses tumor growth and metastasis by regulating the activity of MMP-9 and secretion of VEGF-A which is mediated by the RAS/ERK pathway.Oncogenesis (2014) 3, e119; doi:10.1038/oncsis.2014.33; published online 22 September 2014.
30
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
Regulation of matrix metalloproteinase expression in tumor invasion
Jukka Westermarck, Veli‐Matti Kähäri · The FASEB Journal · 1999 · 1.5K citations
Medicine, Cancer Biology, Oncology +17
Cardiac malformations and midline skeletal defects in mice lacking filamin A
Alan Hart, Joanne Morgan, Jürgen E. Schneider et al. · Human Molecular Genetics · 2006 · 156 citations · Full text